Almirall acquires US skin medications from Allergan for $550m
Spanish pharma company Almirall has completed its $550 million acquisition of five skin medications from Allergan’s Medical Dermatology unit in
Continue reading
Tag: Tazorac
Latest Pharma Industry News
-
Teva launches generic version of Delzicol delayed-release capsules in US
-
Pharma giants bag Lynparza EMA approval for metastatic breast cancer
-
Vaxiion begins VAX014 phase 1 trial in non-muscle invasive bladder cancer
-
ReGenTree begins ARISE-3 trial of RGN-259 eye drops for dry eye syndrome
-
Genentech gets Kadcyla FDA approval for post-surgery treatment of HER2+ EBC
-
Imbed Biosciences secures financing for MicroLyte Ag Antimicrobial Matrix
-
Wayne Pharmaceuticals launches Dr Wayne’s Aspirin in US
-
Dr Reddy’s Laboratories to acquire generic injectable products in the US
-
Ibrance FDA approval : Pfizer breast cancer drug approved for metastatic breast cancer in men
-
Novartis to acquire IFM Tre with eye on immunomodulatory drugs
Business News Today
- Granite Construction bags rail contract from Virgin Trains USA in Orlando
- Goldman Sachs to acquire UK insurance broker Aston Lark from Bowmark
- Clearway Energy breaks ground on 419MW Mesquite Star wind farm in Texas
- GMRE buys four inpatient rehabilitation facilities from CNL Healthcare
- KB Home inaugurates Countryside single-family homes in Ontario Ranch, CA
- Unilever acquires French derma-cosmetic brand Garancia
- Women’s apparel retailer Chico’s FAS rejects Sycamore’s $407m offer
- Fatburger launches Impossible Burger in Singapore fast casual restaurants
- SCG Packaging to buy 55% stake in Indonesian packaging paper company Fajar
- Froneri to acquire Tip Top ice cream business from Fonterra for $250m
